Grendon J H, Digiacomo R F, Frost F J
Office of Toxic Substances, Washington State Department of Health, Olympia 98504.
Public Health Rep. 1991 May-Jun;106(3):322-5.
Dientamoeba fragilis is a pathogenic protozoan parasite that has no cyst stage. Because of the lack of a cyst stage, the laboratory detection of D. fragilis in stool specimens is dependent on the stool processing and examination methods employed. Failure to use recommended stool fixation and permanent staining techniques almost precludes identification of D. fragilis, which is associated with gastrointestinal illness in humans. In this survey, questionnaires were mailed to all State and territorial public health laboratories requesting information on the number of ova and parasite examinations, methods of processing and examining stools, and the number of D. fragilis positive stools for 1985. Forty-three of 54 (80 percent) laboratories responded. Results showed that those laboratories which reported D. fragilis detection examined more stools using recommended stool fixation methods and were more likely to stain permanently all stools examined. Permanent staining of all stools, as compared to loose and watery stools only, resulted in a fivefold greater detection of D. fragilis. More State and territorial public health laboratories reported finding D. fragilis infections in 1985 than in a 1978 survey performed by the Centers for Disease Control. However, in 1985 only six laboratories reported 82 percent of all D. fragilis detections. To increase the probability of detecting D. fragilis in stool specimens, the findings suggest that all stools should be submitted fixed in polyvinyl alcohol fixative, sodium acetate-acetic acid-formalin fixative, or Schaudinn's fixative. Further, all specimens, regardless of consistency, should be permanently stained prior to microscopic examination.
脆弱双核阿米巴是一种没有包囊期的致病性原生动物寄生虫。由于缺乏包囊期,粪便标本中脆弱双核阿米巴的实验室检测取决于所采用的粪便处理和检查方法。不使用推荐的粪便固定和永久染色技术几乎无法识别脆弱双核阿米巴,它与人类胃肠道疾病有关。在这项调查中,向所有州和地区公共卫生实验室邮寄了问卷,询问1985年的虫卵和寄生虫检查数量、粪便处理和检查方法以及脆弱双核阿米巴阳性粪便的数量。54个实验室中有43个(80%)做出了回应。结果表明,那些报告检测到脆弱双核阿米巴的实验室使用推荐的粪便固定方法检查了更多的粪便,并且更有可能对所有检查的粪便进行永久染色。与仅对稀便和水样便进行检查相比,对所有粪便进行永久染色使脆弱双核阿米巴的检测率提高了五倍。与疾病控制中心1978年进行的一项调查相比,更多的州和地区公共卫生实验室报告在1985年发现了脆弱双核阿米巴感染。然而,在1985年,只有6个实验室报告了所有脆弱双核阿米巴检测病例的82%。为了提高在粪便标本中检测到脆弱双核阿米巴的可能性,研究结果表明,所有粪便都应使用聚乙烯醇固定剂、醋酸钠-醋酸-甲醛固定剂或肖丁固定剂固定后送检。此外,所有标本,无论其稠度如何,在显微镜检查前都应进行永久染色。